Why Evolve EarlyPregnancy™ NIPT Plus Screen?

The most comprehensive NIPT option available for singleton pregnancies.

Includes the standard EarlyPregnancy™ NIPT panel plus optional detection of Sex Chromosome Aneuploidies (SCAs) and Microdeletion Disorders.  Additional upgrade to ALL Chromosome Analysis (includes SCAs). 

What conditions do we look for?

EarlyPregnancy™ NIPT Plus Screen determines if singleton pregnancies have elevated risks for the most common chromosomal abnormalities included on the standard EarlyPregnancy™ NIPT panel plus addition detection of microdeletion disorders described in the table below.

CONDITION ESTIMATED INCIDENCE
22q11.2 deletion syndrome 1 in 4,000
1p36 deletion syndrome 1 in 5,000
Prader-Willi syndrome 1 in 10,000
Angelman syndrome 1 in 12,000
Cri du chat syndrome 1 in 20,000
Wolf-Hirschhorn syndrome 1 in 50,000
Learn More

It's Important for all pregnant women to be screened

Professional societies recommend prenatal screening be offered to every women early in pregnancy, regardless of maternal age or risk factors. Pregnancies achieved through assisted reproductive technologies (ART) or in-vitro fertilization (IVF) can also benefit from a prenatal NIPT screen.

You can be screened from the 10th week of pregnancy.

While all pregnant woman can benefit from the EarlyPregnancy™ NIPT Plus Screen, it is particularly suitable for pregnant women who exhibit certain indications including women of advanced maternal age and  pregnancies conceived through IVF.

How can I use my results?

There are many options available to you, once you’ve received your results.  Our Board-Certified Genetic Counselors will help you understand your results in the context of your medical and family history.  It is recommended that no irreversible clinical decisions be made based on these screening results alone.